87 related articles for article (PubMed ID: 29587682)
21. The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis.
Meneses-Echávez JF; Jiménez EG; Río-Valle JS; Correa-Bautista JE; Izquierdo M; Ramírez-Vélez R
BMC Cancer; 2016 Aug; 16(1):682. PubMed ID: 27562357
[TBL] [Abstract][Full Text] [Related]
22. Effects of Exercise on Insulin, IGF Axis, Adipocytokines, and Inflammatory Markers in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Kang DW; Lee J; Suh SH; Ligibel J; Courneya KS; Jeon JY
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):355-365. PubMed ID: 27742668
[No Abstract] [Full Text] [Related]
23. Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors.
Dittus KL; Harvey JR; Bunn JY; Kokinda ND; Wilson KM; Priest J; Pratley RE
BMC Cancer; 2018 Mar; 18(1):351. PubMed ID: 29587682
[TBL] [Abstract][Full Text] [Related]
24. Body weight management in overweight and obese breast cancer survivors.
Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
[TBL] [Abstract][Full Text] [Related]
25. The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema.
Winkels RM; Sturgeon KM; Kallan MJ; Dean LT; Zhang Z; Evangelisti M; Brown JC; Sarwer DB; Troxel AB; Denlinger C; Laudermilk M; Fornash A; DeMichele A; Chodosh LA; Schmitz KH
Contemp Clin Trials; 2017 Oct; 61():63-72. PubMed ID: 28739540
[TBL] [Abstract][Full Text] [Related]
26. Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Travier N; Buckland G; Vendrell JJ; Fernandez-Veledo S; Peiró I; Del Barco S; Pernas S; Zamora E; Bellet M; Margeli M; Cirauqui B; Muñoz M; Tusquets I; Arcusa A; Javierre C; Moreno F; Rodriguez A; Agudo A
Eur J Cancer Care (Engl); 2018 Jul; 27(4):e12861. PubMed ID: 29869823
[TBL] [Abstract][Full Text] [Related]
27. The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.
Santa-Maria CA; Coughlin JW; Sharma D; Armanios M; Blackford AL; Schreyer C; Dalcin A; Carpenter A; Jerome GJ; Armstrong DK; Chaudhry M; Cohen GI; Connolly RM; Fetting J; Miller RS; Smith KL; Snyder C; Wolfe A; Wolff AC; Huang CY; Appel LJ; Stearns V
Clin Cancer Res; 2020 Jun; 26(12):3024-3034. PubMed ID: 32071117
[TBL] [Abstract][Full Text] [Related]
28. Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study.
Harrigan M; Cartmel B; Loftfield E; Sanft T; Chagpar AB; Zhou Y; Playdon M; Li F; Irwin ML
J Clin Oncol; 2016 Mar; 34(7):669-76. PubMed ID: 26598750
[TBL] [Abstract][Full Text] [Related]
29. Obesity, insulin resistance and breast cancer outcomes.
Goodwin PJ
Breast; 2015 Nov; 24 Suppl 2():S56-9. PubMed ID: 26283600
[TBL] [Abstract][Full Text] [Related]
30. Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.
Thompson HJ; Sedlacek SM; Wolfe P; Paul D; Lakoski SG; Playdon MC; McGinley JN; Matthews SB
Nutrients; 2015 Jun; 7(7):5156-76. PubMed ID: 26132992
[TBL] [Abstract][Full Text] [Related]
31. (2) Classification and diagnosis of diabetes.
American Diabetes Association
Diabetes Care; 2015 Jan; 38 Suppl():S8-S16. PubMed ID: 25537714
[No Abstract] [Full Text] [Related]
32. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies.
Chan DSM; Vieira AR; Aune D; Bandera EV; Greenwood DC; McTiernan A; Navarro Rosenblatt D; Thune I; Vieira R; Norat T
Ann Oncol; 2014 Oct; 25(10):1901-1914. PubMed ID: 24769692
[TBL] [Abstract][Full Text] [Related]
33. Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence.
Mann S; Beedie C; Balducci S; Zanuso S; Allgrove J; Bertiato F; Jimenez A
Diabetes Metab Res Rev; 2014 May; 30(4):257-68. PubMed ID: 24130081
[TBL] [Abstract][Full Text] [Related]
34. Role of leptin resistance in the development of obesity in older patients.
Carter S; Caron A; Richard D; Picard F
Clin Interv Aging; 2013; 8():829-44. PubMed ID: 23869170
[TBL] [Abstract][Full Text] [Related]
35. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.
Rock CL; Pande C; Flatt SW; Ying C; Pakiz B; Parker BA; Williams K; Bardwell WA; Heath DD; Nichols JF
Clin Breast Cancer; 2013 Jun; 13(3):188-95. PubMed ID: 23375717
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.
Arcidiacono B; Iiritano S; Nocera A; Possidente K; Nevolo MT; Ventura V; Foti D; Chiefari E; Brunetti A
Exp Diabetes Res; 2012; 2012():789174. PubMed ID: 22701472
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.
Guo S; Liu M; Wang G; Torroella-Kouri M; Gonzalez-Perez RR
Biochim Biophys Acta; 2012 Apr; 1825(2):207-22. PubMed ID: 22289780
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
